Novo Nordisk today announced positive topline results from PIONEER TEENS, a phase 3a trial evaluating oral semaglutide for ...

Rybelsus (semaglutide) is a brand-name oral tablet that’s prescribed for type 2 diabetes. The cost of the drug with and without insurance can depend on several factors, such as whether Rybelsus has a ...

A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds.

Rybelsus (semaglutide) is a brand-name prescription medication that doctors prescribe alongside exercise and diet to help improve blood sugar levels in adults with type 2 diabetes. Plans often group ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Interest surrounding glucagon-like peptide 1 agonists (GLP-1), a class of type 2 diabetes drugs that help ...

Novo Nordisk bets on oral Ozempic launch and pediatric label expansions to counter slowing demand, pricing pressure and ...

Novo Nordisk said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to ...

Down with Rybelsus! No, this isn’t a line from "1984," but rather the new message from Novo Nordisk for its first Rybelsus ad of 2022. One of the biggest issues facing new medicines like Rybelsus, ...

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...

Novo Nordisk said Thursday it will seek federal approval to expand the use of its Ozempic and Rybelsus pills to kids and ...

Rybelsus tablets come in a child-resistant bottle with a blue cap. The bottle is designed to prevent children from accessing the drug. Be sure to keep the bottle out of reach of children. The bottle ...